drugset / Trial / NCT05981768

Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult Smokers

NCT05981768

Phase 1 Completed 30 enrolled Achieve Life Sciences
RandomizedCrossoverOpen-labelTreatment

Summary

To assess the effect of food on the bioavailability of 3 mg cytisinicline following single-dose administration, and to evaluate the PK profile of 3 mg cytisinicline TID following multiple days of administration during Days 5-8.

Timeline

Start
2023-08-08
Primary completion
2023-09-21
Completion
2023-09-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytisinicline Small molecule 3 mg Oral

Indications

No indication recorded.